205 related articles for article (PubMed ID: 15090793)
21. Cloning of human Stat5B. Reconstitution of interleukin-2-induced Stat5A and Stat5B DNA binding activity in COS-7 cells.
Lin JX; Mietz J; Modi WS; John S; Leonard WJ
J Biol Chem; 1996 May; 271(18):10738-44. PubMed ID: 8631883
[TBL] [Abstract][Full Text] [Related]
22. CD127 expression and regulation are altered in the memory CD8 T cells of HIV-infected patients--reversal by highly active anti-retroviral therapy (HAART).
Colle JH; Moreau JL; Fontanet A; Lambotte O; Joussemet M; Delfraissy JF; Thèze J
Clin Exp Immunol; 2006 Mar; 143(3):398-403. PubMed ID: 16487237
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of IL-2-induced Jak-STAT signaling by glucocorticoids.
Bianchi M; Meng C; Ivashkiv LB
Proc Natl Acad Sci U S A; 2000 Aug; 97(17):9573-8. PubMed ID: 10920190
[TBL] [Abstract][Full Text] [Related]
24. Activation of Stat5 by interleukin 2 requires a carboxyl-terminal region of the interleukin 2 receptor beta chain but is not essential for the proliferative signal transmission.
Fujii H; Nakagawa Y; Schindler U; Kawahara A; Mori H; Gouilleux F; Groner B; Ihle JN; Minami Y; Miyazaki T
Proc Natl Acad Sci U S A; 1995 Jun; 92(12):5482-6. PubMed ID: 7777534
[TBL] [Abstract][Full Text] [Related]
25. Staphylococcal enterotoxins modulate interleukin 2 receptor expression and ligand-induced tyrosine phosphorylation of the Janus protein-tyrosine kinase 3 (Jak3) and signal transducers and activators of transcription (Stat proteins).
Nielsen M; Svejgaard A; Röpke C; Nordahl M; Odum N
Proc Natl Acad Sci U S A; 1995 Nov; 92(24):10995-9. PubMed ID: 7479924
[TBL] [Abstract][Full Text] [Related]
26. The role of Stat5a and Stat5b in signaling by IL-2 family cytokines.
Lin JX; Leonard WJ
Oncogene; 2000 May; 19(21):2566-76. PubMed ID: 10851055
[TBL] [Abstract][Full Text] [Related]
27. Interleukin 9 induces expression of three cytokine signal inhibitors: cytokine-inducible SH2-containing protein, suppressor of cytokine signalling (SOCS)-2 and SOCS-3, but only SOCS-3 overexpression suppresses interleukin 9 signalling.
Lejeune D; Demoulin JB; Renauld JC
Biochem J; 2001 Jan; 353(Pt 1):109-116. PubMed ID: 11115404
[TBL] [Abstract][Full Text] [Related]
28. Interleukin-7 signaling in human B cell precursor acute lymphoblastic leukemia cells and murine BAF3 cells involves activation of STAT1 and STAT5 mediated via the interleukin-7 receptor alpha chain.
van der Plas DC; Smiers F; Pouwels K; Hoefsloot LH; Löwenberg B; Touw IP
Leukemia; 1996 Aug; 10(8):1317-25. PubMed ID: 8709637
[TBL] [Abstract][Full Text] [Related]
29. TGF-beta inhibits IL-2-induced tyrosine phosphorylation and activation of Jak-1 and Stat 5 in T lymphocytes.
Bright JJ; Kerr LD; Sriram S
J Immunol; 1997 Jul; 159(1):175-83. PubMed ID: 9200453
[TBL] [Abstract][Full Text] [Related]
30. Signaling through JAK2-STAT5 pathway is essential for IL-3-induced activation of microglia.
Natarajan C; Sriram S; Muthian G; Bright JJ
Glia; 2004 Jan; 45(2):188-96. PubMed ID: 14730712
[TBL] [Abstract][Full Text] [Related]
31. Ovarian carcinoma cells inhibit T cell proliferation: suppression of IL-2 receptor beta and gamma expression and their JAK-STAT signaling pathway.
Wang H; Xie X; Lu WG; Ye DF; Chen HZ; Li X; Cheng Q
Life Sci; 2004 Feb; 74(14):1739-49. PubMed ID: 14741732
[TBL] [Abstract][Full Text] [Related]
32. Distinct effects of STAT5 activation on CD4+ and CD8+ T cell homeostasis: development of CD4+CD25+ regulatory T cells versus CD8+ memory T cells.
Burchill MA; Goetz CA; Prlic M; O'Neil JJ; Harmon IR; Bensinger SJ; Turka LA; Brennan P; Jameson SC; Farrar MA
J Immunol; 2003 Dec; 171(11):5853-64. PubMed ID: 14634095
[TBL] [Abstract][Full Text] [Related]
33. HIV-1 NL4-3, but not IIIB, inhibits JAK3/STAT5 activation in CD4(+) T cells.
Selliah N; Finkel TH
Virology; 2001 Aug; 286(2):412-21. PubMed ID: 11485409
[TBL] [Abstract][Full Text] [Related]
34. Regulatory dysfunction of the interleukin-7 receptor in CD4 and CD8 lymphocytes from HIV-infected patients--effects of antiretroviral therapy.
Colle JH; Moreau JL; Fontanet A; Lambotte O; Joussemet M; Jacod S; Delfraissy JF; Thèze J
J Acquir Immune Defic Syndr; 2006 Jul; 42(3):277-85. PubMed ID: 16810123
[TBL] [Abstract][Full Text] [Related]
35. Activation of STAT5 by IL-4 relies on Janus kinase function but not on receptor tyrosine phosphorylation, and can contribute to both cell proliferation and gene regulation.
Friedrich K; Kammer W; Erhardt I; Brändlein S; Sebald W; Moriggl R
Int Immunol; 1999 Aug; 11(8):1283-94. PubMed ID: 10421786
[TBL] [Abstract][Full Text] [Related]
36. Suppression of IL-2-induced T cell proliferation and phosphorylation of STAT3 and STAT5 by tumor-derived TGF beta is reversed by IL-15.
Campbell JD; Cook G; Robertson SE; Fraser A; Boyd KS; Gracie JA; Franklin IM
J Immunol; 2001 Jul; 167(1):553-61. PubMed ID: 11418694
[TBL] [Abstract][Full Text] [Related]
37. Interleukin-2 therapy restores CD8 cell non-cytotoxic anti-HIV responses in primary infection subjects receiving HAART.
Martinez-Mariño B; Shiboski S; Hecht FM; Kahn JO; Levy JA
AIDS; 2004 Oct; 18(15):1991-9. PubMed ID: 15577620
[TBL] [Abstract][Full Text] [Related]
38. Interleukin-7 can induce the activation of Jak 1, Jak 3 and STAT 5 proteins in murine T cells.
Foxwell BM; Beadling C; Guschin D; Kerr I; Cantrell D
Eur J Immunol; 1995 Nov; 25(11):3041-6. PubMed ID: 7489741
[TBL] [Abstract][Full Text] [Related]
39. Characterization of cytokine differential induction of STAT complexes in primary human T and NK cells.
Yu CR; Young HA; Ortaldo JR
J Leukoc Biol; 1998 Aug; 64(2):245-58. PubMed ID: 9715265
[TBL] [Abstract][Full Text] [Related]
40. Interleukin-2 activation of STAT5 requires the convergent action of tyrosine kinases and a serine/threonine kinase pathway distinct from the Raf1/ERK2 MAP kinase pathway.
Beadling C; Ng J; Babbage JW; Cantrell DA
EMBO J; 1996 Apr; 15(8):1902-13. PubMed ID: 8617237
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
